Skip to content
Rare Medication

Medicine profile

Cisplatin

Platinum-based chemotherapy used in several solid tumor regimens under specialist supervision.

Not listedFDA drug shortage database - checked 20 Sept 2026Shortage page

What this medicine is commonly used for

Cisplatin may be used in oncology protocols where a platinum agent is indicated. Use depends on diagnosis, staging, and institutional protocols.

Informational only. Treatment decisions belong to qualified clinicians and to local labeling.

Shortage and sourcing context

Cisplatin has been reported in shortage situations in multiple regions. Availability depends on manufacturer output, allocation, and local regulations.

Requests are reviewed for licensed buyer status, destination country rules, and documentation needs.

How it is presented

Examples of presentations referenced for this medicine. Actual market presentations vary by country and registration, so check the pack in front of you.

  • Injection
  • Infusion

Strength examples 1 mg/mL

Who typically asks us about this medicine

  • Patients and families who cannot fill a prescription locally
  • Hospital pharmacies managing formulary access during a shortage
  • Clinics with defined treatment pathways and continuity of care
  • Procurement teams coordinating licensed cross-border sourcing

Frequently asked questions

Full reference text(expand)

Platinum-based chemotherapy used in several solid tumor regimens under specialist supervision.

What this medicine is commonly associated with

Cisplatin may be used in oncology protocols where a platinum agent is indicated. Use depends on diagnosis, staging, and institutional protocols.

Shortage and sourcing context

Cisplatin has been reported in shortage situations in multiple regions. Availability depends on manufacturer output, allocation, and local regulations.

Procurement readers and documentation

Teams may attach formulary references, expected delivery windows, and importer details when permitted. This does not change clinical responsibilities.

Procurement notes

Requests are reviewed for licensed buyer status, destination country rules, and documentation needs.

Presentation examples

Dosage forms referenced on this page may include: Injection, Infusion. Strength examples may include: 1 mg/mL. Actual market presentations vary by region and registration.

Important: This page is informational and not a substitute for professional medical advice, local labeling, or institutional protocols.